Rectal Cancer
Rectal cancer is a type of cancer that develops in the rectum, the final section of the large intestine, often leading to symptoms such as changes in bowel habits, rectal bleeding, and abdominal discomfort.
Early Rectal Cancer: FARE Trial with [68Ga]Ga-FAPI-46 PET/CT
We are studying a new imaging method to detect lymph node spread in early rectal cancer patients. This trial aims to see if it provides more accurate results than standard imaging techniques.
≤3 monthsMonitoring phase (IV)No PlaceboStandard MedicinesInjectionGastroenterologyInfectious DiseasesInternal MedicineOtolaryngology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Are you currently pregnant or breastfeeding?
- Can you communicate in Dutch or English?
- Have you received any neoadjuvant treatment for rectal cancer?
- Do you have rectal cancer that has not spread beyond the local area?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC
Surgery
Amstelveen, Netherlands
Sponsor: Amsterdam UMC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.